Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,888.10
(
0.00%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: mcbio post# 116164

Wednesday, 03/09/2011 12:02:55 AM

Wednesday, March 09, 2011 12:02:55 AM

Post# of 257268
VRUS: "if investors do ultimately see that this two-drug combo won't be enough (i.e., if there is viral breakthrough in longer-term studies)."
This 14-day study, obviously, wasn't meant to be "enough." BUT, what if any of the 15 of 16 non-detectables at day 14 do not experience a viral rebound? There weren't any SAE's. VRUS could already be close to a finish line.
This one bears close watching, imo.

"If we don't succeed, we run the risk of failure."
-Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today